SY

Suresh Yamsani

Director Director DIN 00318942
DIN 00318942 First appointment May 1998 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 1998
Shareholding value •••• Premium profile

About Suresh Yamsani

Data last updated:

Suresh Yamsani was a Director at Reichindia Bio - Applications Limited (2011–2017) and Director at Reichindia Pharma Limited (1998–2014). The companies operate in Agriculture and Pharma.

DIN 00318942
Primary Designation Director
Industry Agriculture
First Appointment 09 May 1998

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jun 20112011₹8.10 Cr (FY 2024)Active
Reichindia Pharma Limited U24230TG1995PLC021457
Director09 May 19981995₹9.54 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Reichindia Bio - Applications Limited
Reichindia Pharma Limited
Premium access

Shareholding and investment profile for Suresh Yamsani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Yamsani

Suresh Yamsani was first appointed on 09 May 1998 as Director at Reichindia Pharma Limited. The most recent appointment on record is 28 Jun 2011 at Reichindia Bio - Applications Limited.

Suresh Yamsani held 2 earlier board appointments: Reichindia Bio - Applications Limited (Director, 28 Jun 2011 to 27 Dec 2017); Reichindia Pharma Limited (Director, 09 May 1998 to 02 Jul 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available